NeuroSky MindWave Mobile 2: The Most Affordable Consumer EEG for Beginners and Developers
| | |

NeuroSky MindWave Mobile 2: The Most Affordable Consumer EEG for Beginners and Developers

ByThe Healthcare Discovery Team

A single channel EEG headset that costs less than a fitness tracker, offering the lowest barrier to entry for anyone curious about brainwave monitoring, neurofeedback, and brain computer interface development. The history of transformative technology follows a predictable pattern: expensive, specialized instruments become affordable enough that curious people outside the original expert community can experiment…

Emotiv EPOC X: 14 Channel Research Grade EEG for Brain Mapping and Cognitive Science
| | |

Emotiv EPOC X: 14 Channel Research Grade EEG for Brain Mapping and Cognitive Science

ByThe Healthcare Discovery Team

The most channel dense consumer EEG headset available, offering 14 sensors that approach the spatial resolution of clinical brain monitoring systems at a fraction of the cost and complexity. When researchers at universities around the world began studying how the brain processes attention, emotion, and decision making outside the constraints of a clinical laboratory, they…

Emotiv Insight 2.0: Five Channel EEG Headset for Research and Neurofeedback
| | |

Emotiv Insight 2.0: Five Channel EEG Headset for Research and Neurofeedback

ByThe Healthcare Discovery Team

A wireless five channel EEG headset that bridges the gap between consumer neurofeedback and research grade brain monitoring, with a developer API that has made it one of the most widely used platforms in brain computer interface development. In 2017, a network meta analysis published in PLoS ONE by Catala-Lopez et al. examined 190 randomized…

Muse 2 EEG Headband: Brain Sensing Technology for Meditation and Focus Training
| | |

Muse 2 EEG Headband: Brain Sensing Technology for Meditation and Focus Training

ByThe Healthcare Discovery Team

A consumer EEG headband that translates your brainwave activity into real time audio feedback, turning meditation from a subjective practice into a measurable skill. Most people who try meditation quit within the first two weeks. The reason is not lack of willpower or interest. It is the absence of feedback. Unlike running, where pace and…

GLP-1 drugs longevity medicine and brain neuroprotection research | Healthcare Discovery
| | |

The NAD+ Renaissance: How a Cellular Fuel Molecule Is Rewriting the Science of Brain Aging, Sleep, and Neurodegeneration

ByThe Healthcare Discovery Team

A landmark Nature Aging expert review by 25 scientists, a Science Advances study showing NAD+ reverses Alzheimer’s memory deficits through RNA splicing, and the first human evidence that oral NAD+ precursors reach the brain are converging into one of the most promising cellular health stories of 2026. Here is what the research means for cognitive aging, sleep, and your healthspan.

PEP glycolytic metabolite suppresses cGAS-STING aging inflammation | Healthcare Discovery
| | |

Blood Tests Are Rewriting Alzheimer’s Detection: How P-Tau217, Finger Prick Diagnostics, and Lithium Science Are Transforming Cognitive Aging

ByThe Healthcare Discovery Team

A convergence of 2026 studies in Nature Medicine and Nature Aging is transforming Alzheimer’s detection. The p-tau217 blood test clock predicts symptom onset within three to four years, a finger prick test achieves 86 percent accuracy from home-collected samples, and Harvard researchers have uncovered a lithium depletion mechanism that may yield a new disease-modifying therapy. Here is what the science means for cognitive aging.

The Daily Rounds: Longevity & Health Care Brief | April 5, 2026
| | | |

The Daily Rounds: Longevity & Health Care Brief | April 5, 2026

ByThe Healthcare Discovery Team

🧬 Cellular Reprogramming Enters Human Trials — Life Biosciences has launched the first FDA-approved partial de-aging trial, translating Sinclair's epigenetic reprogramming research from animal models to human medicine.

🧠 Gut-Brain Axis Reverses Memory Loss — Stanford's Nature study shows that correcting age-related gut bacteria shifts restores youthful cognitive performance by reactivating vagus nerve signaling to the hippocampus.

🤖 AI Drug Discovery Reaches Clinical Scale — 173+ AI-designed drug candidates are now in clinical trials, and longevity medicine is being advised to prepare for AI therapeutics to arrive in clinical practice imminently.

🦠 Gut Microbiome as Active Immune Regulator — New research reveals gut bacteria actively inject proteins into cells to modulate immunity, and a microbiome-derived molecule doubled lung cancer immunotherapy response rates in mice.

😴 Circadian Fragmentation Doubles Dementia Risk — A large Neurology journal study found that weak or late-peaking daily activity rhythms more than double the risk of dementia, making circadian optimization a key prevention target.

Person performing resistance training with dumbbells, representing the neuroscience of strength training for brain health and mental wellness
| | |

Resistance Training Is Medicine for Your Brain: What 2026 Research Reveals About Strength Training, Depression, and Cognitive Decline

ByThe Healthcare Discovery Team

A growing body of clinical evidence shows that resistance training reduces depression symptoms as effectively as frontline medications, slows cognitive decline in aging adults, and triggers neurobiological changes that no pill can replicate. A 2025 Cochrane systematic review of 58 trials, a landmark JAMA Psychiatry meta-analysis, and new neuroimaging research from the University of Sydney reveal how lifting heavy things rewires the brain. Here is what the science says, and what you can do about it starting today.

Person performing strength training exercise demonstrating the connection between resistance training and improved sleep quality
| | |

Sleep Regularity May Matter More Than Sleep Duration for How Long You Live: What 60,977 People and Three Landmark Studies Reveal About the Dimension of Sleep Most People Ignore

ByThe Healthcare Discovery Team

A landmark UK Biobank study of 60,977 people found that sleep regularity is a stronger predictor of mortality than sleep duration, reducing all-cause death risk by 30 percent. Combined with a 2026 OHSU population study and the American Heart Association’s new multidimensional sleep health framework, the evidence demands a fundamental shift in how we think about sleep and longevity. Here is what the research says and what you can do about it starting today.

GLP-1 drugs longevity medicine and brain neuroprotection research | Healthcare Discovery
| | |

GLP-1 Drugs and the Brain: Why the Biggest Alzheimer’s Trial Failed but the Science Is Far From Over

ByThe Healthcare Discovery Team

The EVOKE and EVOKE+ trials of oral semaglutide in 3,808 Alzheimer’s patients failed their primary endpoints, but stunning biomarker data, positive liraglutide brain volume results, and consistent real-world evidence from over a million patients suggest GLP-1 receptor agonists may still hold the key to neuroprotection. Here is what the science actually shows and where the field goes next.